APO866 is potent killing agent for most primary cells from patients with various hematologic malignancies
| Disease diagnosis . | Patient sample no. . | FDC, 10 nM, % . |
|---|---|---|
| Acute myeloid leukemia (AML) | ||
| AML-M5 | 1 | 100 |
| AML-M5 | 2 | 99 |
| AML-M5 | 3 | 98 |
| AML-M6 | 4 | 98 |
| AML-M5 | 5 | 96 |
| AML-M5 | 6 | 96 |
| AML-M5 | 7 | 84 |
| Secondary AML | 8 | 83 |
| AML-M3 | 9 | 73 |
| AML-M5 | 10 | 69 |
| Acute lymphoblastic leukemia (ALL) | ||
| ALL-early pre-B | 11 | 100 |
| ALL-pre-B | 12 | 97 |
| ALL -pre-B | 13 | 88 |
| B-chronic lymphocytic leukemia (B-CLL) | ||
| B-CLL | 14 | 100 |
| B-CLL | 15 | 100 |
| B-CLL | 16 | 100 |
| B-CLL | 17 | 99 |
| B-CLL | 18 | 99 |
| B-CLL | 19 | 98 |
| B-CLL | 20 | 98 |
| B-CLL | 21 | 97 |
| B-CLL | 22 | 96 |
| B-CLL | 23 | 95 |
| B-CLL | 24 | 94 |
| B-CLL | 25 | 88 |
| T-large granular lymphocyte leukemia (T-LGL) | ||
| T-LGL | 26 | 93 |
| T-lymphoma (TL) | ||
| TL | 27 | 98 |
| Marginal zone lymphoma (ML) | ||
| ML | 28 | 97 |
| ML | 29 | 96 |
| ML | 30 | 82 |
| Mantle cell lymphoma (MCL) | ||
| MCL | 31 | 97 |
| Follicular lymphoma (FL) | ||
| FL | 32 | 98 |
| Disease diagnosis . | Patient sample no. . | FDC, 10 nM, % . |
|---|---|---|
| Acute myeloid leukemia (AML) | ||
| AML-M5 | 1 | 100 |
| AML-M5 | 2 | 99 |
| AML-M5 | 3 | 98 |
| AML-M6 | 4 | 98 |
| AML-M5 | 5 | 96 |
| AML-M5 | 6 | 96 |
| AML-M5 | 7 | 84 |
| Secondary AML | 8 | 83 |
| AML-M3 | 9 | 73 |
| AML-M5 | 10 | 69 |
| Acute lymphoblastic leukemia (ALL) | ||
| ALL-early pre-B | 11 | 100 |
| ALL-pre-B | 12 | 97 |
| ALL -pre-B | 13 | 88 |
| B-chronic lymphocytic leukemia (B-CLL) | ||
| B-CLL | 14 | 100 |
| B-CLL | 15 | 100 |
| B-CLL | 16 | 100 |
| B-CLL | 17 | 99 |
| B-CLL | 18 | 99 |
| B-CLL | 19 | 98 |
| B-CLL | 20 | 98 |
| B-CLL | 21 | 97 |
| B-CLL | 22 | 96 |
| B-CLL | 23 | 95 |
| B-CLL | 24 | 94 |
| B-CLL | 25 | 88 |
| T-large granular lymphocyte leukemia (T-LGL) | ||
| T-LGL | 26 | 93 |
| T-lymphoma (TL) | ||
| TL | 27 | 98 |
| Marginal zone lymphoma (ML) | ||
| ML | 28 | 97 |
| ML | 29 | 96 |
| ML | 30 | 82 |
| Mantle cell lymphoma (MCL) | ||
| MCL | 31 | 97 |
| Follicular lymphoma (FL) | ||
| FL | 32 | 98 |
FDC indicates fraction of dead cells at 10 nM APO866.